NO20006383L - Fremgangsmåte for behandling - Google Patents

Fremgangsmåte for behandling

Info

Publication number
NO20006383L
NO20006383L NO20006383A NO20006383A NO20006383L NO 20006383 L NO20006383 L NO 20006383L NO 20006383 A NO20006383 A NO 20006383A NO 20006383 A NO20006383 A NO 20006383A NO 20006383 L NO20006383 L NO 20006383L
Authority
NO
Norway
Prior art keywords
treatment
Prior art date
Application number
NO20006383A
Other languages
English (en)
Norwegian (no)
Other versions
NO20006383D0 (no
Inventor
Martin X Steiner
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20006383D0 publication Critical patent/NO20006383D0/no
Publication of NO20006383L publication Critical patent/NO20006383L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20006383A 1998-06-16 2000-12-14 Fremgangsmåte for behandling NO20006383L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9812941.4A GB9812941D0 (en) 1998-06-16 1998-06-16 Method of treatment
PCT/US1999/013623 WO1999065491A1 (en) 1998-06-16 1999-06-16 Method of treatment

Publications (2)

Publication Number Publication Date
NO20006383D0 NO20006383D0 (no) 2000-12-14
NO20006383L true NO20006383L (no) 2000-12-14

Family

ID=10833832

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006383A NO20006383L (no) 1998-06-16 2000-12-14 Fremgangsmåte for behandling

Country Status (20)

Country Link
EP (1) EP1087766A4 (cs)
JP (1) JP2002518330A (cs)
KR (1) KR20010052895A (cs)
CN (1) CN1305379A (cs)
AP (1) AP2000002002A0 (cs)
AU (1) AU740749B2 (cs)
BG (1) BG105127A (cs)
BR (1) BR9911150A (cs)
CA (1) CA2335236A1 (cs)
CZ (1) CZ20004698A3 (cs)
EA (1) EA003584B1 (cs)
GB (1) GB9812941D0 (cs)
HU (1) HUP0102507A3 (cs)
IL (1) IL139943A0 (cs)
NO (1) NO20006383L (cs)
NZ (1) NZ508532A (cs)
PL (1) PL345261A1 (cs)
SK (1) SK19192000A3 (cs)
WO (1) WO1999065491A1 (cs)
ZA (1) ZA200007396B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1313474A2 (en) * 2000-08-28 2003-05-28 Synthon B.V. Paroxetine compositions and processes for making the same
US7396542B2 (en) * 2001-12-28 2008-07-08 Teva Pharmaceutical Industries Ltd. Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
US20060039975A1 (en) * 2004-08-20 2006-02-23 Zalman Vilkov Paroxetine formulations
FR2926221A1 (fr) * 2008-01-14 2009-07-17 Tassin Thomas Compositions permettant la reproduction artificielle des conditions pharmacologiques de la dependance aux drogues addictives telles que opiaces, psychostimulants, tabac et alcool, par la combinaison de nicotine et d'un ligand.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
JPH06502854A (ja) * 1990-11-24 1994-03-31 ビーチャム・グループ・パブリック・リミテッド・カンパニー 老年痴呆、過食症、片頭痛または食欲不振の治療用のパロキセチンの使用
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method

Also Published As

Publication number Publication date
BG105127A (en) 2001-11-30
NZ508532A (en) 2003-08-29
EP1087766A4 (en) 2001-11-21
SK19192000A3 (sk) 2001-05-10
ZA200007396B (en) 2002-02-27
EP1087766A1 (en) 2001-04-04
HUP0102507A3 (en) 2003-12-29
EA200100041A1 (ru) 2001-06-25
JP2002518330A (ja) 2002-06-25
CZ20004698A3 (cs) 2002-02-13
CA2335236A1 (en) 1999-12-23
AU4688599A (en) 2000-01-05
PL345261A1 (en) 2001-12-03
NO20006383D0 (no) 2000-12-14
HUP0102507A2 (hu) 2002-05-29
AU740749B2 (en) 2001-11-15
GB9812941D0 (en) 1998-08-12
AP2000002002A0 (en) 2000-12-31
KR20010052895A (ko) 2001-06-25
IL139943A0 (en) 2002-02-10
WO1999065491A1 (en) 1999-12-23
BR9911150A (pt) 2001-03-06
EA003584B1 (ru) 2003-06-26
CN1305379A (zh) 2001-07-25

Similar Documents

Publication Publication Date Title
DE69828821D1 (de) Wasserbehandlungsverfahren
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ID27191A (id) Metode untuk pengobatan insomnia
DE69943089D1 (de) Methode zur behandlung von staphylokokkeninfektionen
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO20006383D0 (no) Fremgangsmåte for behandling
ID22607A (id) Proses perlakuan bahan-bahan tekstil
ID26083A (id) Paroksetina 10-kamforsulfonat untuk pengobatan gangguan cns
NO20012301D0 (no) Ny fremgangsmåte for behandling
MD676F1 (ro) Metoda de tratament al rinosinuzitelor Method for treatment of the rhinosinusitis
NO996166D0 (no) Fremgangsmåte for behandling av avluter
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ID24521A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
EE9800006A (et) Jäätmete töötlemise meetod
ID29414A (id) Pengobatan depresi
UA25504A (uk) Спосіб лікуваhhя дисбактеріозу hосоглотки
UA33970A (uk) Спосіб лікування періодонтиту
ID26641A (id) Metoda pengobatan
SE9802791D0 (sv) Behandlingsmetod
EG24158A (en) Novel method of treatment
UA33595A (uk) Спосіб лікування простої шизофренії
GB9824871D0 (en) Novel method of treatment
GB9824790D0 (en) Novel method of treatment